Onderneming Aeolus Pharmaceuticals, Inc. Other OTC
Aandelen
AOLS
US00765G1094
Biotechnologie & Medisch Onderzoek
Vakgebied
Verkoop per activiteit
USD in miljoen | 2015 | Gewicht | 2016 | Gewicht | Delta |
---|---|---|---|---|---|
Biopharmaceutical
100,0
%
| 3 | 100,0 % | 2 | 100,0 % | -33,27% |
Verkoop per regio
USD in miljoen | 2015 | Gewicht | 2016 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 3 | 100,0 % | 2 | 100,0 % | -33,27% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
John McManus
CEO | Chief Executive Officer | 60 | 01-06-05 |
David Cavalier
CHM | Chairman | 54 | 30-04-04 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
David Cavalier
CHM | Chairman | 54 | 30-04-04 |
Jeffrey Scott
BRD | Director/Board Member | 67 | 08-05-13 |
John Clerici
BRD | Director/Board Member | 54 | 08-05-13 |
Amit Kumar
BRD | Director/Board Member | 59 | 01-06-04 |
Chris Rallis
BRD | Director/Board Member | 70 | 01-06-04 |
John Farah
BRD | Director/Board Member | 72 | 21-10-05 |
Mitchell Kaye
BRD | Director/Board Member | 56 | 08-05-13 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 152 085 825 | 152 085 825 ( 100,00 %) | 0 | 100,00 % |
Aandeel B | 0 | 4 500 | 0 | 0 |
Bedrijfsgegevens
Aeolus Pharmaceuticals, Inc.
26361 Crown Valley Parkway Suite 150
92691-7324, Mission Viejo
+949-481-9825
![Adres Aeolus Pharmaceuticals, Inc.(AOLS)](https://cdn.zonebourse.com/static/address/12428722.png)
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+46,91% | 56,61 mld. | |
-7,52% | 39,62 mld. | |
+36,02% | 39,25 mld. | |
-6,90% | 28,28 mld. | |
+11,50% | 26,44 mld. | |
-16,88% | 20,12 mld. | |
+29,75% | 12,51 mld. | |
+29,87% | 12,48 mld. | |
-1,09% | 12,2 mld. |